Children with certain genetic defects affecting hunger control can become severely obese from the age of one or two. Findings suggest that medicines based on GLP-1 hormone may work.
The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World Health Organisation and Columbia University.
Study analysed data from over 540,000 adults in Finland and the UK. To study worldwide estimates, the researchers then used global data from the Global Burden of Diseases (GBD) Study.
These facilities have locked gates and perimeter fencing with huge walls on all sides, and no participant can willingly leave during the course unless they have a valid reason.
An enemy of brown fat is the AC3-AT protein—found within the fat itself—which can shut down brown fat’s activation and cancel out its calorie-burning benefits.
Modi reinforced his previous recommendations to address the crisis, urging families to purchase 10% less cooking oil, and reduce its consumption by the same margin on a regular basis.
Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, as per estimates.
As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.
New Delhi’s new modus operandi vis-à-vis responding to Pakistan undermines Islamabad’s asymmetric nuclear posture, particularly its battlefield nuclear weapons.
India's richest civic body’s outlay is 8.77% higher than last year’s, with the biggest allocation being made for infra growth. BMC also proposed an AI boost to its service delivery.
COMMENTS